Ceftazidime - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for ceftazidime and what is the scope of freedom to operate?
Ceftazidime
is the generic ingredient in ten branded drugs marketed by Acs Dobfar, Aurobindo Pharma Ltd, Wockhardt, B Braun, Glaxosmithkline, Pai Holdings Pharm, Hospira, Lilly, and Baxter Hlthcare, and is included in sixteen NDAs. Additional information is available in the individual branded drug profile pages.There are seventeen drug master file entries for ceftazidime. Three suppliers are listed for this compound.
Summary for ceftazidime
US Patents: | 0 |
Tradenames: | 10 |
Applicants: | 9 |
NDAs: | 16 |
Drug Master File Entries: | 17 |
Finished Product Suppliers / Packagers: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 42 |
Clinical Trials: | 68 |
Patent Applications: | 7,033 |
Drug Prices: | Drug price trends for ceftazidime |
What excipients (inactive ingredients) are in ceftazidime? | ceftazidime excipients list |
DailyMed Link: | ceftazidime at DailyMed |
Recent Clinical Trials for ceftazidime
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Tata Memorial Centre | Phase 2 |
Qianfoshan Hospital | N/A |
Arrevus Inc. | Phase 2 |
Pharmacology for ceftazidime
Drug Class | Cephalosporin Antibacterial |
Medical Subject Heading (MeSH) Categories for ceftazidime
Anatomical Therapeutic Chemical (ATC) Classes for ceftazidime
US Patents and Regulatory Information for ceftazidime
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Glaxosmithkline | PENTACEF | ceftazidime | INJECTABLE;INJECTION | 064008-001 | Mar 31, 1992 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Hospira | TAZICEF | ceftazidime | INJECTABLE;INJECTION | 062662-003 | Mar 6, 1986 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Lilly | TAZIDIME IN PLASTIC CONTAINER | ceftazidime | INJECTABLE;INJECTION | 062739-002 | Jul 10, 1986 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Pai Holdings Pharm | FORTAZ IN PLASTIC CONTAINER | ceftazidime sodium | INJECTABLE;INJECTION | 050634-003 | Apr 28, 1989 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Aurobindo Pharma Ltd | CEFTAZIDIME | ceftazidime | INJECTABLE;INJECTION | 065482-001 | May 28, 2010 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Hospira | TAZICEF | ceftazidime | INJECTABLE;INJECTION | 062662-001 | Mar 6, 1986 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.